Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1543 entries
Sorted by: Best Match Show Resources per page
Liability of manufacturers and providers of health related goods and services: confronting the dilemma.

American journal of law & medicine

Cooper T.
PMID: 1052111
Am J Law Med. 1976-1977 Winter;2(2):257-62.

In this Article, Theodore Cooper, M.D., Assistant Secretary for Health at HEW, contends that the crush of lawsuits brought by aggrieved health care consumers against medical professionals and institutions, and drug and medical equipment manufacturers, may be the result,...

Cite
Cooper T. Liability of manufacturers and providers of health related goods and services: confronting the dilemma. Am J Law Med. 1976;2(2):257-62
Cooper, T. (1976). Liability of manufacturers and providers of health related goods and services: confronting the dilemma. American journal of law & medicine, 2(2), 257-62.
Cooper, T. "Liability of manufacturers and providers of health related goods and services: confronting the dilemma." American journal of law & medicine vol. 2,2 (1976): 257-62.
Cooper T. Liability of manufacturers and providers of health related goods and services: confronting the dilemma. Am J Law Med. 1976-1977 Winter;2(2):257-62. PMID: 1052111.
Copy Download .nbib Format: NLM
Practitioners' obligation: to the public or the drug industry?.

DICP : the annals of pharmacotherapy

Sarkar PK, Das SK.
PMID: 2728509
DICP. 1989 Feb;23(2):175-6. doi: 10.1177/106002808902300215.

No abstract available.

Cite
Sarkar PK, Das SK. Practitioners' obligation: to the public or the drug industry?. DICP. 1989;23(2):175-6doi: 10.1177/106002808902300215.
Sarkar, P. K., & Das, S. K. (1989). Practitioners' obligation: to the public or the drug industry?. DICP : the annals of pharmacotherapy, 23(2), 175-6. https://doi.org/10.1177/106002808902300215
Sarkar, P K, and Das, S K. "Practitioners' obligation: to the public or the drug industry?." DICP : the annals of pharmacotherapy vol. 23,2 (1989): 175-6. doi: https://doi.org/10.1177/106002808902300215
Sarkar PK, Das SK. Practitioners' obligation: to the public or the drug industry?. DICP. 1989 Feb;23(2):175-6. doi: 10.1177/106002808902300215. PMID: 2728509.
Copy Download .nbib Format: NLM
Industry-university alliances in biomedical research.

Journal of clinical pharmacology

Cuatrecasas P.
PMID: 1613118
J Clin Pharmacol. 1992 Feb;32(2):100-6. doi: 10.1002/j.1552-4604.1992.tb03813.x.

No abstract available.

Cite
Cuatrecasas P. Industry-university alliances in biomedical research. J Clin Pharmacol. 1992;32(2):100-6doi: 10.1002/j.1552-4604.1992.tb03813.x.
Cuatrecasas, P. (1992). Industry-university alliances in biomedical research. Journal of clinical pharmacology, 32(2), 100-6. https://doi.org/10.1002/j.1552-4604.1992.tb03813.x
Cuatrecasas, P. "Industry-university alliances in biomedical research." Journal of clinical pharmacology vol. 32,2 (1992): 100-6. doi: https://doi.org/10.1002/j.1552-4604.1992.tb03813.x
Cuatrecasas P. Industry-university alliances in biomedical research. J Clin Pharmacol. 1992 Feb;32(2):100-6. doi: 10.1002/j.1552-4604.1992.tb03813.x. PMID: 1613118.
Copy Download .nbib Format: NLM
The consumer's risk in clinical trials.

Molecular biotherapy

Kramer BS.
PMID: 2222896
Mol Biother. 1990 Sep;2(3):132-6.

In any formal statistical test of the null hypothesis (the statement that a population parameter is equal to a specific value), there are two possible types of error. Type 1 or alpha error has occurred if the investigator rejects...

Cite
Kramer BS. The consumer's risk in clinical trials. Mol Biother. 1990;2(3):132-6
Kramer, B. S. (1990). The consumer's risk in clinical trials. Molecular biotherapy, 2(3), 132-6.
Kramer, B S. "The consumer's risk in clinical trials." Molecular biotherapy vol. 2,3 (1990): 132-6.
Kramer BS. The consumer's risk in clinical trials. Mol Biother. 1990 Sep;2(3):132-6. PMID: 2222896.
Copy Download .nbib Format: NLM
[An interview with Dr. D. Poggiolini, director of the Pharmaceutical Service of the Health Ministry and the Drug Committee of the EEC. Interview by Giuseppe Lojacono].

Epidemiologia e prevenzione

Poggiolini D.
PMID: 2978859
Epidemiol Prev. 1988 Dec;10(37):9.

No abstract available.

Cite
Poggiolini D. Intervista al dott. D. Poggiolini, direttore del servizio Farmaceutico del Ministero della Sanità e del Comitato dei Farmaci della CEE. [An interview with Dr. D. Poggiolini, director of the Pharmaceutical Service of the Health Ministry and the Drug Committee of the EEC. Interview by Giuseppe Lojacono]. Epidemiol Prev. 1988;10(37):9
Poggiolini, D. (1988). Intervista al dott. D. Poggiolini, direttore del servizio Farmaceutico del Ministero della Sanità e del Comitato dei Farmaci della CEE. [An interview with Dr. D. Poggiolini, director of the Pharmaceutical Service of the Health Ministry and the Drug Committee of the EEC. Interview by Giuseppe Lojacono]. Epidemiologia e prevenzione, 10(37), 9.
Poggiolini, D. "Intervista al dott. D. Poggiolini, direttore del servizio Farmaceutico del Ministero della Sanità e del Comitato dei Farmaci della CEE." [An interview with Dr. D. Poggiolini, director of the Pharmaceutical Service of the Health Ministry and the Drug Committee of the EEC. Interview by Giuseppe Lojacono]. Epidemiologia e prevenzione vol. 10,37 (1988): 9.
Poggiolini D. Intervista al dott. D. Poggiolini, direttore del servizio Farmaceutico del Ministero della Sanità e del Comitato dei Farmaci della CEE. [An interview with Dr. D. Poggiolini, director of the Pharmaceutical Service of the Health Ministry and the Drug Committee of the EEC. Interview by Giuseppe Lojacono]. Epidemiol Prev. 1988 Dec;10(37):9. Italian. PMID: 2978859.
Copy Download .nbib Format: NLM
The challenge of industrial veterinary medicine.

Journal of the American Veterinary Medical Association

Hanson J.
PMID: 2644180
J Am Vet Med Assoc. 1989 Jan 01;194(1):42-4.

No abstract available.

Cite
Hanson J. The challenge of industrial veterinary medicine. J Am Vet Med Assoc. 1989;194(1):42-4
Hanson, J. (1989). The challenge of industrial veterinary medicine. Journal of the American Veterinary Medical Association, 194(1), 42-4.
Hanson, J. "The challenge of industrial veterinary medicine." Journal of the American Veterinary Medical Association vol. 194,1 (1989): 42-4.
Hanson J. The challenge of industrial veterinary medicine. J Am Vet Med Assoc. 1989 Jan 01;194(1):42-4. PMID: 2644180.
Copy Download .nbib Format: NLM
Industry and dermatology research: how well can they work together?.

Dermatology nursing

van Rijswijk L, Caldwell-Brown D.
PMID: 2147383
Dermatol Nurs. 1990 Dec;2(6):339-42.

Nursing roles in clinical research are expanding as biomedical technology advances and corporate funding for patient-oriented research increases. Collaboration between nurse investigators and industrial sponsors can lead to the successful application of new knowledge and improved health care if...

Cite
van Rijswijk L, Caldwell-Brown D. Industry and dermatology research: how well can they work together?. Dermatol Nurs. 1990;2(6):339-42
van Rijswijk, L., & Caldwell-Brown, D. (1990). Industry and dermatology research: how well can they work together?. Dermatology nursing, 2(6), 339-42.
van Rijswijk, L, and Caldwell-Brown, D. "Industry and dermatology research: how well can they work together?." Dermatology nursing vol. 2,6 (1990): 339-42.
van Rijswijk L, Caldwell-Brown D. Industry and dermatology research: how well can they work together?. Dermatol Nurs. 1990 Dec;2(6):339-42. PMID: 2147383.
Copy Download .nbib Format: NLM
"Innovation in the Pharmaceutical Industry".

British medical journal

Schwartzman D.
PMID: 638522
Br Med J. 1978 Apr 08;1(6117):919. doi: 10.1136/bmj.1.6117.919-a.
Free PMC Article

No abstract available.

Cite
Schwartzman D. "Innovation in the Pharmaceutical Industry". Br Med J. 1978;1(6117):919doi: 10.1136/bmj.1.6117.919-a.
Schwartzman, D. (1978). "Innovation in the Pharmaceutical Industry". British medical journal, 1(6117), 919. https://doi.org/10.1136/bmj.1.6117.919-a
Schwartzman, D. ""Innovation in the Pharmaceutical Industry"." British medical journal vol. 1,6117 (1978): 919. doi: https://doi.org/10.1136/bmj.1.6117.919-a
Schwartzman D. "Innovation in the Pharmaceutical Industry". Br Med J. 1978 Apr 08;1(6117):919. doi: 10.1136/bmj.1.6117.919-a. PMID: 638522; PMCID: PMC1603706.
Copy Download .nbib Format: NLM
The pharmaceutical industry: a national resource.

Health affairs (Project Hope)

Cooper T.
PMID: 2289759
Health Aff (Millwood). 1990;9(4):222-3. doi: 10.1377/hlthaff.9.4.222-b.

No abstract available.

Cite
Cooper T. The pharmaceutical industry: a national resource. Health Aff (Millwood). 1990;9(4):222-3doi: 10.1377/hlthaff.9.4.222-b.
Cooper, T. (1990). The pharmaceutical industry: a national resource. Health affairs (Project Hope), 9(4), 222-3. https://doi.org/10.1377/hlthaff.9.4.222-b
Cooper, T. "The pharmaceutical industry: a national resource." Health affairs (Project Hope) vol. 9,4 (1990): 222-3. doi: https://doi.org/10.1377/hlthaff.9.4.222-b
Cooper T. The pharmaceutical industry: a national resource. Health Aff (Millwood). 1990;9(4):222-3. doi: 10.1377/hlthaff.9.4.222-b. PMID: 2289759.
Copy Download .nbib Format: NLM
[Great Britain's foreign trade in drugs].

Meditsinskaia promyshlennost' SSSR

Voevodin EN.
PMID: 6000067
Med Prom SSSR. 1966 Oct;20(10):60-4.

No abstract available.

Cite
Voevodin EN. Vneshniaia torgovlia anglii medikamentami. [Great Britain's foreign trade in drugs]. Med Prom SSSR. 1966;20(10):60-4
Voevodin, E. N. (1966). Vneshniaia torgovlia anglii medikamentami. [Great Britain's foreign trade in drugs]. Meditsinskaia promyshlennost' SSSR, 20(10), 60-4.
Voevodin, E N. "Vneshniaia torgovlia anglii medikamentami." [Great Britain's foreign trade in drugs]. Meditsinskaia promyshlennost' SSSR vol. 20,10 (1966): 60-4.
Voevodin EN. Vneshniaia torgovlia anglii medikamentami. [Great Britain's foreign trade in drugs]. Med Prom SSSR. 1966 Oct;20(10):60-4. Russian. PMID: 6000067.
Copy Download .nbib Format: NLM
[Survival or decline of the pharmaceutical industry?].

La Nouvelle presse medicale

Schwob M.
PMID: 7355096
Nouv Presse Med. 1980 Jan 12;9(3):148.

No abstract available.

Cite
Schwob M. Survie ou déclin de l'industrie pharmaceutique? [Survival or decline of the pharmaceutical industry?]. Nouv Presse Med. 1980;9(3):148
Schwob, M. (1980). Survie ou déclin de l'industrie pharmaceutique? [Survival or decline of the pharmaceutical industry?]. La Nouvelle presse medicale, 9(3), 148.
Schwob, M. "Survie ou déclin de l'industrie pharmaceutique?" [Survival or decline of the pharmaceutical industry?]. La Nouvelle presse medicale vol. 9,3 (1980): 148.
Schwob M. Survie ou déclin de l'industrie pharmaceutique? [Survival or decline of the pharmaceutical industry?]. Nouv Presse Med. 1980 Jan 12;9(3):148. French. PMID: 7355096.
Copy Download .nbib Format: NLM
The current reorganization and function of the division of new drugs.

Pharmakotherapia

Ruskin A.
PMID: 5875716
Pharmakotherapia. 1964;2(1):212-5.

No abstract available.

Cite
Ruskin A. The current reorganization and function of the division of new drugs. Pharmakotherapia. 1964;2(1):212-5
Ruskin, A. (1964). The current reorganization and function of the division of new drugs. Pharmakotherapia, 2(1), 212-5.
Ruskin, A. "The current reorganization and function of the division of new drugs." Pharmakotherapia vol. 2,1 (1964): 212-5.
Ruskin A. The current reorganization and function of the division of new drugs. Pharmakotherapia. 1964;2(1):212-5. PMID: 5875716.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1543 entries